Core Viewpoint - 康耐特光学 reported a revenue of RMB 1.084 billion for the six months ending June 30, 2025, representing an increase of 11.04% year-on-year [1] - The profit attributable to the owners of the parent company was RMB 273 million, reflecting a year-on-year increase of 30.73% [1] - The company proposed an interim dividend of RMB 0.15 per ordinary share (tax included) [1] Revenue and Profit Growth - The increase in revenue and profit was primarily due to the orderly expansion of both international and domestic businesses [1] - Sales of high value-added products showed stable growth [1] - Upgrades to automated production lines effectively improved production and labor efficiency while reducing production costs [1]

Group 1 - The company, 康耐特光学 (02276), announced a mid-term dividend of HKD 0.15 per share for the six months ending June 30, 2025, to be distributed on October 15, 2025 [1]

Core Viewpoint - 康耐特光学 announced a mid-term dividend of HKD 0.15 per share for the six months ending June 30, 2025, to be distributed on October 15, 2025 [1] Company Summary - 康耐特光学 will distribute a mid-term dividend of HKD 0.15 per share [1]

Group 1 - The company reported a revenue of approximately RMB 1,084.2 million for the six months ending June 30, 2025, representing an increase of about 11.1% compared to the same period in 2024 [1] - The gross profit was approximately RMB 444.3 million, reflecting a year-on-year increase of about 16.2% [1] - The profit attributable to the owners of the parent company was approximately RMB 272.9 million, which is an increase of about 30.7% compared to 2024 [1] Group 2 - The board of directors has proposed an interim dividend of RMB 0.15 per share (before tax) for the six months ending June 30, 2025 [1]

EF001 發行人所發行上市權證/可轉換債券的相關信息 發行人所發行上市權證/可轉換債券 不適用 其他信息 其他信息 不適用 發行人董事 於本公告日期，董事會包括執行董事費錚翔先生、鄭育紅先生、夏國平先生、陳俊華先生、王傳寶先生及曹雪女士；非執行董事趙 曉雲女士及田克漢先生；及獨立非執行董事肖斐博士、陳一先生、吳瑩博士及金益亭先生。 第 2 頁 共 2 頁 v 1.1.1 EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | --- | --- | | 股票發行人現金股息公告 | | | 發行人名稱 | 上海康耐特光學科技集團股份有限公司 | | 股份代號 | 02276 | | 多櫃檯股份代號及貨幣 | 不適用 | | 相關股份代號及名稱 | 不適用 | | 公告標題 | 截至2025年6月30日止六個月之中期股息 | | 公告日期 | 2025年8月8日 | | 公告狀態 | 新公告 | | 股息信息 | | | 股息 ...

[Performance Summary](index=1&type=section&id=%E6%91%98%E8%A6%81) The company achieved approximately RMB 1,084.2 million in revenue, a 11.1% year-on-year increase, with profit attributable to owners of the parent growing by 30.7% Performance Indicators (RMB million) | Indicator | H1 2025 | Year-on-year Growth | | :--- | :--- | :--- | | Revenue | Approx. 1,084.2 | +11.1% | | Gross Profit | Approx. 444.3 | +16.2% | | Profit attributable to owners of the parent | Approx. 272.9 | +30.7% | | Earnings per share (RMB) | Approx. 0.59 | +18.0% | | Proposed interim dividend (RMB per share, pre-tax) | 0.15 | - | [Financial Statements](index=2&type=section&id=%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8) This section provides an overview of the Group's consolidated financial statements, including profit or loss, comprehensive income, and financial position [Consolidated Statement of Profit or Loss](index=2&type=section&id=%E5%90%88%E5%B9%B6%E6%8D%9F%E7%9B%8A%E8%A1%A8) In H1 2025, the Group's revenue reached RMB 1.084 billion, a 11.1% year-on-year increase; profit before tax was RMB 317 million, up 29.0%; and profit for the period was RMB 273 million, up 30.7%, with basic and diluted earnings per share at RMB 0.59 Consolidated Statement of Profit or Loss (RMB thousand) | Item | H1 2025 (Unaudited) | H1 2024 (Unaudited) | Year-on-year Change | | :--- | :--- | :--- | :--- | | Revenue | 1,084,235 | 976,396 | +11.1% | | Gross Profit | 444,280 | 382,354 | +16.2% | | Profit before tax | 316,851 | 245,698 | +29.0% | | Profit for the period | 272,865 | 208,732 | +30.7% | | Earnings per share (RMB) | 0.59 | 0.50 | +18.0% | [Consolidated Statement of Comprehensive Income](index=3&type=section&id=%E5%90%88%E5%B9%B6%E7%BB%BC%E5%90%88%E6%94%B6%E7%9B%8A%E8%A1%A8) Profit for the period was RMB 273 million, with an additional RMB 8.04 million from exchange differences on translation of overseas operations, resulting in a total comprehensive income of RMB 281 million for the period, a 29.6% year-on-year increase Consolidated Statement of Comprehensive Income (RMB thousand) | Item | H1 2025 (Unaudited) | H1 2024 (Unaudited) | Year-on-year Change | | :--- | :--- | :--- | :--- | | Profit for the period | 272,865 | 208,732 | +30.7% | | Exchange differences on translation of overseas operations | 8,042 | 7,959 | +1.0% | | Total comprehensive income for the period | 280,907 | 216,691 | +29.6% | [Consolidated Statement of Financial Position](index=4&type=section&id=%E5%90%88%E5%B9%B6%E8%B4%A2%E5%8A%A1%E7%8A%B6%E5%86%B5%E8%A1%A8) As of June 30, 2025, the Group's total assets increased to RMB 3.251 billion, total liabilities decreased to RMB 735 million, and net assets significantly grew to RMB 2.516 billion, with net current assets increasing substantially, indicating a sound financial position Consolidated Statement of Financial Position (RMB thousand) | Item | June 30, 2025 (Unaudited) | December 31, 2024 (Audited) | Change | | :--- | :--- | :--- | :--- | | Total non-current assets | 842,954 | 769,809 | +9.5% | | Total current assets | 2,407,840 | 1,618,975 | +48.7% | | **Total Assets** | **3,250,794** | **2,388,784** | **+36.1%** | | Total current liabilities | 663,966 | 732,228 | -9.3% | | Total non-current liabilities | 70,981 | 70,999 | -0.03% | | **Total Liabilities** | **734,947** | **803,227** | **-8.5%** | | **Net Assets** | **2,515,847** | **1,585,557** | **+58.7%** | [Notes to the Financial Statements](index=6&type=section&id=%E8%B4%A2%E5%8A%A1%E6%8A%A5%E8%A1%A8%E9%99%84%E8%A7%A3) This section details the Group's operating segments, revenue breakdown, income tax, dividends, and trade receivables, providing further context to the financial statements [Operating Segments and Geographical Information](index=8&type=section&id=2%20%E7%BB%8F%E8%90%A5%E5%88%86%E9%83%A8%E8%B5%84%E6%96%99) The Group operates a single business segment, primarily manufacturing and selling resin spectacle lenses, with Mainland China and Asia (excluding Mainland China) being the main revenue sources, accounting for 33.1% and 27.3% of total revenue respectively, and non-current assets primarily concentrated in Mainland China, Japan, and Thailand - The Group primarily operates in a single business segment, manufacturing and selling resin spectacle lenses, thus no segment information is presented[18](index=18&type=chunk) Revenue from External Customers (RMB thousand) | Region | H1 2025 | Percentage | H1 2024 | Percentage | | :--- | :--- | :--- | :--- | :--- | | Mainland China | 359,151 | 33.1% | 301,823 | 30.9% | | Asia (excluding Mainland China) | 295,423 | 27.3% | 241,074 | 24.7% | | Americas | 220,120 | 20.3% | 224,178 | 22.9% | | Europe | 170,518 | 15.7% | 160,937 | 16.5% | | Other | 39,023 | 3.6% | 48,384 | 5.0% | | **Total** | **1,084,235** | **100.0%** | **976,396** | **100.0%** | - For the six months ended June 30, 2025, revenue from the single largest customer was approximately **RMB 100 million**, accounting for approximately **9.2%** of total revenue[21](index=21&type=chunk) [Revenue, Other Income and Gains](index=9&type=section&id=3%20%E6%94%B6%E5%85%A5%E3%80%81%E5%85%B6%E4%BB%96%E6%94%B6%E7%9B%8A%E5%8F%8A%E6%89%80%E5%BE%97) Total revenue of RMB 1.084 billion was entirely derived from contracts with customers, with standardized lenses contributing the most at RMB 513 million, a 19.9% year-on-year increase, while functional lenses revenue was RMB 382 million, up 8.8%, and other income and gains primarily stemmed from bank interest income and government grants Revenue by Product Type (RMB thousand) | Product Type | H1 2025 | H1 2024 | Year-on-year Change | | :--- | :--- | :--- | :--- | | Standardized lenses | 512,505 | 427,205 | +19.9% | | Functional lenses | 382,266 | 351,410 | +8.8% | | Customized lenses | 184,872 | 194,365 | -4.9% | | Other | 4,592 | 3,416 | +34.4% | | **Total** | **1,084,235** | **976,396** | **+11.1%** | - Other income and gains amounted to **RMB 29.21 million**, a **7.8%** year-on-year increase, primarily due to bank interest income rising from **RMB 2.39 million** to **RMB 9.70 million**[24](index=24&type=chunk) [Income Tax](index=12&type=section&id=6.%20%E6%89%80%E5%BE%97%E7%A8%8E%E8%B4%B9%E7%94%A8) Income tax expense for the period was RMB 43.99 million, a 19.0% year-on-year increase, mainly due to increased profit, with certain Chinese subsidiaries (Jiangsu Conant and Shanghai Conant) enjoying a 15% preferential tax rate for high-tech enterprises, while other subsidiaries apply statutory tax rates of their respective regions - Jiangsu Conant Optical Co., Ltd. and Shanghai Conant Optical Co., Ltd., subsidiaries of the Group, are recognized as "High-tech Enterprises" and enjoy a **15%** preferential corporate income tax rate[28](index=28&type=chunk) Income Tax Expense (RMB thousand) | Tax Item | H1 2025 | H1 2024 | Year-on-year Change | | :--- | :--- | :--- | :--- | | Current tax | 45,010 | 33,833 | +33.0% | | Deferred tax expense | (1,024) | 3,133 | - | | **Total income tax expense for the period** | **43,986** | **36,966** | **+19.0%** | [Dividends](index=14&type=section&id=7.%20%E8%82%A1%20%E6%81%AF) The Board recommended an interim dividend of RMB 0.15 per share (pre-tax) for the six months ended June 30, 2025, and the 2024 final dividend of RMB 0.16 per share was approved and is scheduled for payment on August 11, 2025 - The Board recommended an interim dividend of **RMB 0.15** per ordinary share (pre-tax) for 2025[31](index=31&type=chunk)[63](index=63&type=chunk) - The 2024 final dividend of **RMB 0.16** per share (pre-tax), totaling **RMB 76.79 million**, was approved at the annual general meeting on June 14, 2025, and is scheduled for payment on August 11, 2025[31](index=31&type=chunk)[70](index=70&type=chunk) [Trade and Bills Receivables](index=15&type=section&id=10.%20%E5%BA%94%E6%94%B6%E8%B4%A6%E6%AC%BE%E5%8F%8A%E5%BA%94%E6%94%B6%E7%A5%A8%E6%8D%AE) Net trade receivables increased from RMB 356 million to RMB 419 million, with receivables within three months accounting for the largest proportion, and the Group has recognized an impairment provision of RMB 61.11 million using a provision matrix and purchased insurance to mitigate credit risk Aging Analysis of Trade Receivables (RMB thousand) | Aging Period | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Within 3 months | 318,519 | 305,441 | | 3 to 6 months | 90,764 | 41,772 | | 6 to 12 months | 8,667 | 7,569 | | 1 to 2 years | 668 | 1,080 | | **Total** | **418,618** | **355,862** | - The Group uses a provision matrix to measure expected credit losses; as of June 30, 2025, the gross carrying amount of trade receivables was **RMB 480 million**, with an expected credit loss provision of **RMB 61.11 million**, resulting in an overall expected credit loss rate of **12.7%**[38](index=38&type=chunk) [Management Discussion and Analysis](index=18&type=section&id=%E7%AE%A1%E7%90%86%E5%B1%82%E8%AE%A8%E8%AE%BA%E4%B8%8E%E5%88%86%E6%9E%90) This section analyzes the Group's business performance, financial results, capital structure, and outlines significant investments and future strategic plans [Business Review and Outlook](index=18&type=section&id=%E4%B8%9A%E5%8A%A1%E5%9B%9E%E9%A1%BE%E5%8F%8A%E5%B1%95%E6%9C%9B) In H1 2025, the company achieved double-digit growth in revenue and profit through steady expansion of domestic and international business, primarily driven by increased sales of high-value-added products and optimized production efficiency, with future plans to increase R&D, expand overseas production capacity (Japan, Thailand), and actively advance XR business - H1 2025 performance growth is primarily attributable to: (i) orderly expansion of international and domestic business, with stable growth in sales of high-value-added products; and (ii) upgraded automated production lines improving production efficiency and reducing costs[42](index=42&type=chunk) - Future Outlook: - Continue to increase R&D and optimize product structure - Enhance automation levels and expand overseas production capacity, with Japan's customized production line and Thailand's production base to be advanced in the second half of the year - Maintain a differentiated high-end product strategy in the domestic market to increase market share - Continuously advance XR business, collaborating with domestic and international customers, with some projects already achieving product delivery[43](index=43&type=chunk)[44](index=44&type=chunk) [Financial Performance Analysis](index=20&type=section&id=%E8%B4%A2%E5%8A%A1%E8%A1%A8%E7%8E%B0%E5%88%86%E6%9E%90) Revenue grew by 11.1% to RMB 1.084 billion, and the gross profit margin increased from 39.2% to 41.0%, primarily due to increased sales of high-refractive index and multi-functional lenses, with gross profit margins improving across all lens types, and financial asset impairment losses significantly decreasing by 59.1% due to effective cost control - Revenue increased by **11.1%** year-on-year, primarily due to (i) sales growth achieved through various channels; and (ii) continuous upgrading of products and services and optimization of product portfolio[45](index=45&type=chunk) - Overall gross profit margin increased from **39.2%** to **41.0%**, primarily due to increased sales of high-refractive index lenses and multi-functional lenses[47](index=47&type=chunk) Product Segment Gross Profit Margin | Product Segment | H1 2025 | H1 2024 | | :--- | :--- | :--- | | Standardized lenses | 33.6% | 30.8% | | Functional lenses | 40.6% | 37.8% | | Customized lenses | 61.9% | 59.5% | - Impairment loss on financial assets significantly decreased by **59.1%** year-on-year to **RMB 3.20 million**, primarily due to an increased collection rate of receivables[53](index=53&type=chunk) [Capital Structure, Liquidity and Funding](index=22&type=section&id=%E8%B5%84%E6%9C%AC%E6%9E%B6%E6%9E%84) As of the period end, total assets increased by 36.1%, total liabilities decreased by 8.5%, and the gearing ratio decreased from 33.6% to 22.6%, with the current ratio increasing from 2.2 times to 3.6 times, and cash and cash equivalents increasing to RMB 786 million, primarily due to proceeds from additional share issuance, leading to a decrease in the debt-to-equity ratio (total borrowings/total equity) to 8.2% Financial Ratios | Financial Ratio | June 30, 2025 | December 31, 2024 | | :--- | :--- | :--- | | Gearing ratio (Total liabilities/Total assets) | 22.6% | 33.6% | | Current ratio | 3.6 times | 2.2 times | | Debt-to-equity ratio (Total borrowings/Total equity) | 8.2% | 18.3% | - Cash and cash equivalents increased from **RMB 499 million** to **RMB 786 million**, a **57.5%** year-on-year increase, primarily due to the receipt of proceeds from the additional share issuance by Hong Kong Goertek Co., Limited[58](index=58&type=chunk) - As of June 30, 2025, total bank credit facilities amounted to **RMB 722 million**, with **RMB 206 million** utilized[60](index=60&type=chunk) [Material Investments and Future Plans](index=26&type=section&id=%E9%87%8D%E5%A4%A7%E6%8A%95%E8%B5%84) In H1, the Group held financial wealth management products valued at RMB 531 million, and is advancing the construction of its Thailand production base, having paid RMB 92.27 million for land, while also planning to invest approximately USD 4 million in Japan to build a high-end customized lens production line to deepen its global footprint - As of June 30, 2025, the Group held financial assets measured at fair value through profit or loss amounting to **RMB 531 million**, primarily funds or wealth management products issued by large financial institutions[68](index=68&type=chunk) - Material investment plans include: - Thailand investment: Accumulated land payments of **RMB 92.27 million** for the construction of factory buildings and supporting facilities - Japan investment: Plans to invest approximately **USD 4 million** through a subsidiary to build an automated lens production line for resin lenses, focusing on high-end customized lenses[69](index=69&type=chunk) [Other Information](index=27&type=section&id=%E5%85%B6%E4%BB%96%E8%B5%84%E6%96%99) This section provides additional information on the Group's share repurchases, new share issuances, and the utilization of proceeds from past offerings [Share Repurchases and Issuance](index=30&type=section&id=%E8%B4%AD%E4%B9%B0%E3%80%81%E5%87%BA%E5%94%AE%E6%88%96%E5%9B%9E%E8%B4%AD%E6%9C%AC%E5%85%AC%E5%8F%B8%E4%B8%8A%E5%B8%82%E8%AF%81%E5%88%B8) In H1 2025, the company repurchased 2.2 million shares through the trustee of its share award scheme, and additionally, placed and issued 53.325 million new H shares to Hong Kong Goertek Co., Limited in January 2025 - In H1 2025, **2.2 million** shares of the company's listed securities were repurchased through the trustee of the share award scheme[80](index=80&type=chunk) - On January 6, 2025, **53,325,000** H shares were placed and issued to Hong Kong Goertek Co., Limited at a placing price of **HKD 15.86**[80](index=80&type=chunk) [Use of Proceeds](index=31&type=section&id=%E6%9C%AA%E6%9D%A5%E8%AE%A1%E5%88%92%E5%8F%8A%E6%89%80%E5%BE%97%E6%AC%BE%E9%A1%B9%E7%94%A8%E9%80%94) As of June 30, 2025, approximately 98.6% of the net proceeds of HKD 474 million from the 2021 global offering have been utilized, and approximately HKD 49.3 million of the net proceeds of approximately HKD 829 million from the January 2025 H share placing have been used, primarily for R&D, design, and manufacturing of lenses and visual solutions for smart glasses and XR headsets - As of June 30, 2025, approximately **HKD 467 million** of the net proceeds of approximately **HKD 474 million** from the 2021 global offering have been utilized, representing a utilization rate of **98.6%**[82](index=82&type=chunk) - Approximately **HKD 49.3 million** of the net proceeds of approximately **HKD 829 million** from the January 2025 H share placing have been used for R&D, design, and manufacturing of lenses and visual solutions for smart glasses and XR head-mounted devices; approximately **HKD 351 million** of the remaining proceeds have been temporarily arranged for subscription of financial products[84](index=84&type=chunk)

Group 1 - The article provides a list of companies involved in various financial activities such as earnings announcements, shareholder meetings, and new stock activities [2][3] - Several companies are mentioned for their dividend distribution dates, indicating their financial performance and shareholder returns [2][3] - The document highlights companies undergoing stock repurchases and capital increases, which may signal their financial strategies and market positioning [3] Group 2 - The article includes a list of companies that are currently in the process of IPOs, reflecting market interest and potential investment opportunities [2] - Companies like Silver Noble Pharmaceuticals and others are noted for their ongoing stock activities, which may attract investor attention [2] - The document also mentions companies that are resuming trading, indicating a potential recovery or change in market conditions [2]

Summary of 康耐特光学 Conference Call Company Overview - 康耐特光学 is a leading manufacturer of high-refractive index lenses, specifically 1.74 refractive index lenses, with a strong market presence in China and globally, covering regions such as the US, Japan, India, Australia, Thailand, Germany, and Brazil [2][6][17]. Financial Projections - Revenue projections for 康耐特光学 over the next three years are expected to be 2.43 billion, 2.86 billion, and 3.36 billion RMB, with a stable year-on-year growth rate of 17%-18% [2][3]. - Net profit forecasts for the same period are 535 million, 650 million, and 786 million RMB, with year-on-year growth rates of 21%-25% [2][3]. - The company has experienced a compound annual growth rate (CAGR) of 16.8% in revenue and 35% in net profit over the past five years [2][9]. Product and Market Dynamics - 康耐特光学's product offerings include standardized lenses, customized lenses, and functional lenses, with a significant focus on high-margin customized lenses, which have a gross margin of 58% compared to 32% for standardized lenses [11][12]. - The global lens market is projected to reach $67.7 billion by 2028, with a CAGR of 6.2%, driven by increasing myopia rates and demand for functional products [4][15]. - The Chinese lens market is expected to grow to 48.9 billion RMB by 2028, with a CAGR of 7.1% [4][15]. Competitive Positioning - 康耐特光学 has a competitive pricing strategy, with 1.74 refractive index lenses priced between 50-60 RMB, which is competitive against major players like Zeiss and Essilor [12]. - The company has reduced its overall expense ratio from 21.8% in 2020 to 16.2% currently, while increasing R&D expenditure to 4.3% [13]. Strategic Partnerships - 康耐特光学 has deepened its collaboration with 歌尔股份, which holds a 20% stake in the company, to advance their smart glasses business [2][7]. Management and Ownership Structure - The founder, 费振祥, holds a 44% stake, with the management team having extensive industry experience [8]. Industry Trends - The smart glasses market is anticipated to grow significantly, with projections indicating a market size increase from 17.9 billion RMB in 2025 to 178.1 billion RMB by 2030, reflecting a CAGR of 58% [4][20]. - The global penetration rate of AI smart glasses is expected to reach 70% by 2035, indicating a strong future demand for such products [4][18]. Conclusion - 康耐特光学 is well-positioned in the optical lens market with strong financial growth, competitive pricing, and strategic partnerships, particularly in the emerging smart glasses segment. The company's focus on high-margin products and efficient operational models, such as C2M, further enhances its competitive edge and profitability potential [22].

Core Viewpoint - 康耐特光学 announced a change in the trading unit of its ordinary H shares on the Hong Kong Stock Exchange, reducing the trading unit from 500 shares to 100 shares, effective from August 29, 2025 [1] Company Summary - 康耐特光学's ordinary H shares will have a new trading unit of 100 shares, which is a significant reduction from the previous unit of 500 shares [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Shanghai Conant Optical Co., Ltd. 上海康耐特光學科技集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：2276） 更改每手買賣單位 上海康耐特光學科技集團股份有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣 佈，本公司普通H股（「股份」）於香港聯合交易所有限公司（「聯交所」）買賣之每手買賣 單位將由500股股份更改為100股股份，自二零二五年八月二十九日（星期五）上午九時正 起生效。 股份現時以每手500股之買賣單位進行交易，而根據股份於本公告日期在聯交所所報收市 價每股43.7港元計算，每手股份之市值為21,850港元。於更改每手買賣單位生效後，股份 將以每手100股之買賣單位進行交易，而根據股份於本公告日期在聯交所所報收市價每股 43.7港元計算，屆時每手股份之市值估計將為4,370港元。更改每手買賣單位將降低股份 每手買賣單位之 ...